Unihealth Hospitals Ltd
Unihealth Hospitals Q4 FY25 earnings call: Revenue & Margins
Q4 FY25 earnings call: what management guided on revenue, margins and order book.
The short version
Expansion underway to add 250 beds in India (Mumbai and Nasik) and 100-150 beds in East Africa this year, aiming for 300-400 new beds in total. FY '25 showed strong growth: consolidated income up 16%, EBITDA at INR 21.32 crores, net profit up nearly 47% to INR 15.14 crores.
From Unihealth Hospitals Ltd's Q4 FY25 earnings-call transcript · updated 23 Aug 2026.
Revenue & Sales Performance
- Expansion underway to add 250 beds in India (Mumbai and Nasik) and 100-150 beds in East Africa this year, aiming for 300-400 new beds in total.
- Target to cross 1,000 beds across India and Africa within the next 3 years.
- India’s contribution to consolidated revenue expected to rise to about 30%-35% over next 1-2 years as new Indian facilities become operational.
- Uganda remains a mature, significant revenue contributor, but will form less than one-third of consolidated revenue in future.
- Revenue realization anticipated to increase in next 2 years aligned with project cycles and commissioning of new facilities, such as Navi Mumbai in July.
- Consultancy business expected to grow but hospital and medical centers will remain primary growth drivers.
2 more points from Unihealth Hospitals Ltd's call on revenue
Pro opens every point from 15K+ earnings calls
Profitability & Margins
See what Unihealth Hospitals Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Planned capital investment of INR 50 to 75 crores for this year to add around 300 beds in Nasik and East Africa.
- Capex mainly funded through internal accruals and part from INR 10.5 crores raised via warrant issue.
- Exploring banking facilities in India for equipment finance and working capital limits.
- Expansion includes adding beds in Mumbai (60 beds currently), Nasik (190 beds), and potential Pune project under discussion for next financial year.
- Open to raising additional capital through promoters infusing funds, preferential allotment, public fundraise, and possible debt, depending on requirements.
2 more points from Unihealth Hospitals Ltd's call on capex
Pro opens every point from 15K+ earnings calls
Top-ranked in Healthcare Services
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Unihealth Hospitals Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
2 more points from Unihealth Hospitals Ltd's call on order book
Pro opens every point from 15K+ earnings calls
Continue your research
What Unihealth Hosp's management said in earlier quarters
Others in Healthcare Services this season
- 3B Blackbio (Q4 FY25)
UK subsidiary (TRUPCR Europe Limited) revenue FY 2024-25: GBP 1,287,580, a 94% increase over FY 2023-24 GBP 664,059. Key concall takeaways from 3B Blackbio DX…
- Apollo Hospitals (Q4 FY25)
. Key concall takeaways from Apollo Hospitals Enterprise Ltd's Q4 FY25 earnings call — and how it ranks against sector peers.
- Shalby (Q4 FY25)
Implant business is in high-growth mode: 4x growth in Indonesia, 35-40% growth in U.S., and 2.5x growth in India reported last year. Key concall takeaways from…
- Suraksha Diagno. (Q4 FY25)
Volume of tests conducted has been growing at around 10% year-on-year between FY '24 and FY '25. Key concall takeaways from Suraksha Diagnostic Ltd's Q4 FY25…
Arthneeti Pro · Annual
Unihealth Hospitals Ltd and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Unihealth Hospitals Ltd Q4 FY25 results?
Expansion underway to add 250 beds in India (Mumbai and Nasik) and 100-150 beds in East Africa this year, aiming for 300-400 new beds in total. FY '25 showed strong growth: consolidated income up 16%, EBITDA at INR 21.32 crores, net profit up nearly 47% to INR 15.14 crores.
What is Unihealth Hospitals Ltd share price analysis?
Unihealth Hospitals Ltd currently shows a neutral. The stock trades at a P/E of 41.9 with a market cap of ₹1,075 Cr. Investors should review the full earnings analysis for detailed insights.
Is Unihealth Hospitals Ltd planning capital expenditure?
Planned capital investment of INR 50 to 75 crores for this year to add around 300 beds in Nasik and East Africa.
Keep Unihealth Hospitals Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.